Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Unexpected role for Immuno-oncology in SCCOHT

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.07.18
Views: 620

Dr Douglas Levine - NYU Langone Medical Center, New York, USA

Dr Levine speaks with ecancer at BCGS 2018 about small cell carcinoma of the ovary - hypercalcemic type, a rare disease with low trial support.

He discusses the discovery of a single gene responsible for the disease, and how this is impacting the development of treatment with immune agents and cell-cycle regulators.

Dr Levine also spoke with ecancer about lowgrade serous carcinoma, here.

Related videos

follow us

Tobacco Dependence e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation